Cargando…
Economic evaluation of a novel genetic screening test for risk of venous thromboembolism compared with standard of care in women considering combined hormonal contraception in Switzerland
AIM: The aim of this study was to assess the cost effectiveness of the Pill Protect (PP) genetic screening test for venous thromboembolism (VTE) risk compared with standard of care (SoC), for women considering combined hormonal contraceptives (CHCs) in Switzerland. METHODS: A two-part microsimulatio...
Autores principales: | Sutherland, C Simone, Ademi, Zanfina, Michaud, Joëlle, Schur, Nadine, Lingg, Myriam, Bhadhuri, Arjun, Pache, Thierry D., Bitzer, Johannes, Suchon, Pierre, Albert, Valerie, Hersberger, Kurt E., Tanackovic, Goranka, Schwenkglenks, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858234/ https://www.ncbi.nlm.nih.gov/pubmed/31699733 http://dx.doi.org/10.1136/bmjopen-2019-031325 |
Ejemplares similares
-
Risk prediction of developing venous thrombosis in combined oral contraceptive users
por: McDaid, Aaron, et al.
Publicado: (2017) -
Herpes zoster vaccine: A health economic evaluation for Switzerland
por: Blank, Patricia R., et al.
Publicado: (2017) -
Cost Effectiveness and Budget Impact of Siponimod Compared to Interferon Beta-1a in the Treatment of Adult Patients with Secondary Progressive Multiple Sclerosis with Active Disease in Switzerland
por: Schur, Nadine, et al.
Publicado: (2021) -
Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland
por: Bhadhuri, Arjun, et al.
Publicado: (2022) -
Analysis of in situ pre-mRNA targets of human splicing factor SF1 reveals a function in alternative splicing
por: Corioni, Margherita, et al.
Publicado: (2011)